| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | lenalidomide | FIMM | pan-cancer | AAC | -0.017 | 0.9 |
| mRNA | BMS-536924 | GDSC1000 | pan-cancer | AAC | -0.0032 | 0.9 |
| mRNA | Vinorelbine | GDSC1000 | pan-cancer | AAC | -0.0034 | 0.9 |
| mRNA | WP1130 | CTRPv2 | pan-cancer | AAC | 0.0035 | 0.9 |
| mRNA | linifanib | GDSC1000 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.005 | 0.9 |
| mRNA | carboplatin:etoposide (40:17 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | ML320 | CTRPv2 | pan-cancer | AAC | 0.0032 | 0.9 |
| mRNA | lovastatin | CTRPv2 | pan-cancer | AAC | -0.0033 | 0.9 |
| mRNA | KW-2449 | CTRPv2 | pan-cancer | AAC | -0.0027 | 0.9 |